Fr. 237.00

Anti-inflammatory Nutraceuticals and Chronic Diseases

Inglese · Tascabile

Spedizione di solito entro 6 a 7 settimane

Descrizione

Ulteriori informazioni

This comprehensive volume focuses on anti-inflammatory nutraceuticals and their role in various chronic diseases. Food and Drug Administration (FDA) approved drugs such as steroids, non-steroidal anti-inflammatory drugs (NSAIDS), statins and metformin have been shown to modulate inflammatory pathways, but their long-term intake has been associated with numerous side effects. This means that there is enormous potential for dietary agents that can modulate inflammatory pathways in humans. Leading experts describe the latest research on the role of anti-inflammatory nutraceuticals in preventing and treating chronic diseases.

Sommario

Curcuminand Its Role in Chronic Diseases.- Berberine and its Role in Chronic Disease.- Emodin and Its Role in Chronic Diseases.- Ursolic acid and chronic disease: An overview of UA's effects on prevention and treatment of obesity and cancer.- Tocotrienol and its Role in Chronic Diseases.- Indole-3-carbinol and its Role in Chronic Diseases.- Sanguinarine and its Role in Chronic Diseases.- Piperine and its Role in Chronic Diseases.- Therapeutic Potential and Molecular Targets of Piceatannol in Chronic Diseases.- Fisetin and its Role in Chronic Diseases.







Info autore










Dr. Subash Gupta is currently an Assistant professor at Department of Biochemistry, Institute of Science, Banaras Hindu University, India. 
Dr. Sahdeo Prasad is currently at the Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, USA.


Dr. Bharat Aggarwal is currently a Founding Director, Inflammation Research Institute, San Diego, California, USA. He was a Ransom Horne, Jr. Distinguished Professor of Experimental Therapeutics, Cancer Medicine and Immunology, The University of Texas MD Anderson Cancer Center, USA.




Riassunto

This comprehensive volume focuses on anti-inflammatory nutraceuticals and their role in various chronic diseases. Food and Drug Administration (FDA) approved drugs such as steroids, non-steroidal anti-inflammatory drugs (NSAIDS), statins and metformin have been shown to modulate inflammatory pathways, but their long-term intake has been associated with numerous side effects. This means that there is enormous potential for dietary agents that can modulate inflammatory pathways in humans. Leading experts describe the latest research on the role of anti-inflammatory nutraceuticals in preventing and treating chronic diseases.

Dettagli sul prodotto

Con la collaborazione di Bharat B Aggarwal (Editore), Bharat B. Aggarwal (Editore), Bharat B Aggarwal (Editore), Subash Chandra Gupta (Editore), Sahde Prasad (Editore), Sahdeo Prasad (Editore)
Editore Springer, Berlin
 
Lingue Inglese
Formato Tascabile
Pubblicazione 01.01.2018
 
EAN 9783319823263
ISBN 978-3-31-982326-3
Pagine 482
Dimensioni 154 mm x 24 mm x 237 mm
Peso 747 g
Illustrazioni VIII, 482 p. 61 illus., 35 illus. in color.
Serie Advances in Experimental Medicine and Biology
Advances in Experimental Medicine and Biology
Categorie Scienze naturali, medicina, informatica, tecnica > Medicina > Branche non cliniche

B, Diätetik und Ernährung, Lebensmittel- und Getränketechnologie, Immunology, Pharmakologie, Nutrition, biochemistry, Pharmacology, Food Science, Biomedical and Life Sciences, Food—Biotechnology, Food & beverage technology, Pharmacology/Toxicology

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.